We are live on
!
Find out more
LSB
LakeShore Biopharma
Delisted
LSB was delisted on the 19th of September, 2025.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
O
1
OrbiMed
New York
| $486K | +$412K | +140,428 | New |
|
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
| $402K | +$3 | +1 | +0% |
|
| 3 |
HA
3
HHLR Advisors
Grand Cayman,
Cayman Islands
| $259K | – | – | – |
|
| 4 |
SCM
4
Superstring Capital Management
New York
| $106K | – | – | – |
|
| 5 |
5
Barclays
London,
United Kingdom
| $85.7K | -$3 | -1 | -0% |
|
| 6 |
6
UBS Group
Zurich,
Switzerland
| $3.25K | -$11.7K | -4,002 | -81% |
|
| 7 |
7
Fidelity International
Hamilton,
Bermuda
| – | -$424K | -61,548 | Closed |
|
| 8 |
8
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$75.5K | -9,381 | Closed |
|